MycoTechnology’s Honey Truffle Sweetener on Track to Revolutionize Sugar Reduction

The new product, made from a sweet protein found in honey truffles discovered only a year ago , is described as a game-changing alternative to sugar and artificial sweeteners. It has a clean taste profile and is 1000 to 2500 times sweeter than sucrose. “This progress is a reflection of Myco’s unique ability to integrate discovery with commercial development” Leveraging precision fermentation , MycoTechnology claims to have successfully scaled production from a lab bench to 3000 L tanks.

Moreover, per to the notice, the business’s team is improving production and developing efficient strains to make the honey truffle sweetener economically competitive with similar products. Moreover, in silico analysis has indicated that the molecule has minimal potential for adverse effects beyond sweetness, as it breaks down into amino acids commonly found in other protein sources like chicken. Going to MycoTechnology, it is working on regulatory submissions in key global jurisdictions.

With a worldwide patent portfolio and interest from leading industry partners, the business states it is poised to impact the future of sweeteners and sugar reduction with its game-changing product. © MycoTechnology Fungi and fermentation MycoTechnology, founded in 2013 in Aurora, Colorado, utilizes advanced fermentation technology to produce innovative mushroom-based elements. With $220 million in backing from various shareholders, the business has introduced an 86,000 sq ft facility and offers products like FermentIQ plant proteins and the mycelium-derived savor modulator ClearIQ — the star ingredient of the sugar-free sweet dark chocolate bar Macalat .

Sue Potter, Senior Director of Regulatory Affairs at the firm, shares: “Following global best practices in partnership with world-class sector experts, our conclusions suggest that honey truffle sweetener is likely to be an ideal general-purpose sweetener for foods and beverages. We’re confident in the results we’ve received so far, and we’re on track for regulatory submissions in key global jurisdictions.”